NOAH logo
NOAH Statement On NI Veterinary Medicines
3 days ago 
118 views
From 1 January 2026 the regulatory environment for veterinary medicines in Northern Ireland will change, with EU laws being applied in full, when the current transition period ends. NOAH member companies have invested a huge amount of time and resource over the past two years to make the required regulatory, supply chain and logistical changes to ensure that discontinuations of veterinary medicinal products on the NI market are minimised as much as possible.
The current assessment by the UK government is that around 10-15% of products authorised for Northern Ireland will be discontinued. While this is concerning, the UK government has also worked hard to protect animal health and welfare by developing two schemes, whereby vets and other retailers will be able to apply for access to veterinary medicinal products from elsewhere, should product shortages arise. UK government and the Veterinary Medicines Directorate have also worked closely with industry to develop useful guidance for all stakeholders to mitigate against any anticipated product shortages.
NOAH calls on Northern Ireland based stakeholders to maintain close dialogue with the animal health industry, the VMD and policy makers, to highlight where product shortages may arise. In the medium term, NOAH calls on government to work to improve and refine regulatory procedures and processes, with the aim of ensuring that unnecessary regulatory burden does not act as a barrier to the long-term availability of veterinary medicines.
As a matter of urgency, we also call on both UK government and the European Commission, to work together to develop a Veterinary Medicines Agreement, to ensure availability of veterinary medicines in both the UK and EU with the associated animal health and welfare and economic benefits that this will bring.
Guidance is available on the Veterinary Medicines Internal Market Scheme (VMIMS); and on the Veterinary Medicine Health Situation Scheme (VMHSS)on the Veterinary Medicines Directorate website.
More from NOAH
- NOAH achieves Silver accreditation in Investors in the Environment (iiE) Programme
- NOAH comment on the Government response to the GB Veterinary Medicines Regulation
- Political perspectives at the NOAH Conference 1 February ‘Animal health and securing our future – a vital connection’: book now
- Make it your New Year’s Resolution to ‘Paws to Protect’
- New NOAH report on the contribution animal health makes to One Health and sustainability
3 days ago